ES536550A0 - Procedimiento para preparar derivados de cefalosporina - Google Patents

Procedimiento para preparar derivados de cefalosporina

Info

Publication number
ES536550A0
ES536550A0 ES536550A ES536550A ES536550A0 ES 536550 A0 ES536550 A0 ES 536550A0 ES 536550 A ES536550 A ES 536550A ES 536550 A ES536550 A ES 536550A ES 536550 A0 ES536550 A0 ES 536550A0
Authority
ES
Spain
Prior art keywords
procedure
cephalosporin derivatives
preparing cephalosporin
preparing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES536550A
Other languages
English (en)
Other versions
ES8603497A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES536550A0 publication Critical patent/ES536550A0/es
Publication of ES8603497A1 publication Critical patent/ES8603497A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES536550A 1983-10-08 1984-10-05 Procedimiento para preparar derivados de cefalosporina Expired ES8603497A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3336756 1983-10-08
DE19843409431 DE3409431A1 (de) 1983-10-08 1984-03-15 Cephalosporinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES536550A0 true ES536550A0 (es) 1985-12-16
ES8603497A1 ES8603497A1 (es) 1985-12-16

Family

ID=25814731

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536550A Expired ES8603497A1 (es) 1983-10-08 1984-10-05 Procedimiento para preparar derivados de cefalosporina

Country Status (13)

Country Link
EP (1) EP0137440A3 (es)
KR (1) KR850002991A (es)
AU (1) AU3388384A (es)
DE (1) DE3409431A1 (es)
DK (1) DK479684A (es)
ES (1) ES8603497A1 (es)
FI (1) FI843933L (es)
GR (1) GR80574B (es)
HU (1) HU190878B (es)
IL (1) IL73190A0 (es)
MA (1) MA20250A1 (es)
NO (1) NO844006L (es)
PT (1) PT79317B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
DE3419013A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
CA1267647A (en) * 1984-12-27 1990-04-10 Ryosuke Ushijima Cephalosporin derivatives
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
DE3506159A1 (de) * 1985-02-22 1986-08-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3789466T2 (de) * 1986-03-17 1994-07-28 Fujisawa Pharmaceutical Co 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung.
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
AT388919B (de) * 1987-04-01 1989-09-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinderivaten
US4929612A (en) * 1987-04-17 1990-05-29 Eisai Co., Ltd. Thiadiazolylacetamide cephem derivatives
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
EP1618114B1 (en) * 2003-04-16 2010-07-14 Sandoz AG Processes for the preparations of cefepime
WO2007096740A2 (en) * 2006-02-20 2007-08-30 Orchid Research Laboratories Limited Novel cephalosporins
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3100732A1 (en) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH644867A5 (de) * 1978-10-27 1984-08-31 Glaxo Group Ltd In der 3- und 7-stellung substituierte cephemcarbonsaeuren.
GR78245B (es) * 1980-09-12 1984-09-26 Ciba Geigy Ag
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins

Also Published As

Publication number Publication date
IL73190A0 (en) 1985-01-31
FI843933A0 (fi) 1984-10-05
AU3388384A (en) 1985-04-18
DK479684D0 (da) 1984-10-05
DE3409431A1 (de) 1985-04-18
EP0137440A3 (de) 1986-01-08
MA20250A1 (fr) 1985-07-01
HUT37152A (en) 1985-11-28
HU190878B (en) 1986-11-28
GR80574B (en) 1985-02-01
KR850002991A (ko) 1985-05-28
ES8603497A1 (es) 1985-12-16
PT79317A (de) 1984-11-01
FI843933L (fi) 1985-04-09
NO844006L (no) 1985-04-09
PT79317B (de) 1986-10-20
DK479684A (da) 1985-04-09
EP0137440A2 (de) 1985-04-17

Similar Documents

Publication Publication Date Title
ES535978A0 (es) Procedimiento para preparar derivados de tiazol
ES500792A0 (es) Procedimiento para preparar derivados de cefalosporina
ES548323A0 (es) Procedimiento para preparar derivados de benzodifuranona
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
ES536550A0 (es) Procedimiento para preparar derivados de cefalosporina
ES536138A0 (es) Procedimiento para preparar derivados azolicos
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
MX161088A (es) Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida
ES547466A0 (es) Procedimiento de preparacion de derivados aminometilfosfoni-cos
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES541687A0 (es) Procedimiento para preparar cefalosporinas
ES533624A0 (es) Procedimiento para la preparacion de derivados de tiazolidina
ES539314A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
MX157788A (es) Procedimiento para preparar derivados de oxima
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES524830A0 (es) Procedimiento para preparar derivados de xantina
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES528166A0 (es) Un procedimiento para preparar derivados de cefalosporina
ES527164A0 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
ES521847A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES530573A0 (es) Procedimiento para preparar derivados de pirazol-1,5-a-piridina
ES528807A0 (es) Procedimiento para preparar compuestos de ftalocianina